{"transactions":[{"id":674722,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-26T21:56:14.000Z","date":"2026-08-25","kind":"gift","planned":true,"acquired":true,"shares":50092,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pravin Dugel 2024 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On August 25, 2026, the reporting person's spouse transferred 50,092 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":744903,"source":{"system":"sec-edgar","filing":"0001104659-26-101667","document":"tm2624096-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926101667/tm2624096-1_4seq1.xml","form_type":"4"}},{"id":674721,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-26T21:56:14.000Z","date":"2026-08-25","kind":"gift","planned":true,"acquired":false,"shares":50092,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On August 25, 2026, the reporting person's spouse transferred 50,092 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-101667","document":"tm2624096-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926101667/tm2624096-1_4seq1.xml","form_type":"4"}},{"id":674720,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-26T21:56:14.000Z","date":"2026-08-24","kind":"sale","planned":true,"acquired":false,"shares":21649,"price":10.77,"value":233159.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.6400 to $10.9000, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":2525429,"source":{"system":"sec-edgar","filing":"0001104659-26-101667","document":"tm2624096-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926101667/tm2624096-1_4seq1.xml","form_type":"4"}},{"id":731753,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-18T20:01:15.000Z","date":"2026-06-16","kind":"gift","planned":false,"acquired":true,"shares":50092,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 16, 2026, the reporting person transferred 50,092 shares to his spouse for no consideration."}],"balance_after":50092,"source":{"system":"sec-edgar","filing":"0001104659-26-075709","document":"tm2618141-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926075709/tm2618141-1_4seq1.xml","form_type":"4"}},{"id":731752,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-18T20:01:15.000Z","date":"2026-06-16","kind":"gift","planned":false,"acquired":false,"shares":50092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 16, 2026, the reporting person transferred 50,092 shares to his spouse for no consideration."}],"balance_after":2547078,"source":{"system":"sec-edgar","filing":"0001104659-26-075709","document":"tm2618141-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926075709/tm2618141-1_4seq1.xml","form_type":"4"}},{"id":759925,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-28T20:08:06.000Z","date":"2026-05-28","kind":"gift","planned":true,"acquired":true,"shares":394696,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pravin Dugel 2024 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On May 28, 2026, the reporting person's spouse transferred 394,696 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":694811,"source":{"system":"sec-edgar","filing":"0001104659-26-067485","document":"tm2615856-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926067485/tm2615856-4_4seq1.xml","form_type":"4"}},{"id":759924,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-28T20:08:06.000Z","date":"2026-05-28","kind":"gift","planned":true,"acquired":false,"shares":394696,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On May 28, 2026, the reporting person's spouse transferred 394,696 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-067485","document":"tm2615856-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926067485/tm2615856-4_4seq1.xml","form_type":"4"}},{"id":759923,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-28T20:08:06.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":21156,"price":8.2,"value":173479.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.1450 to $8.2521, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":2597170,"source":{"system":"sec-edgar","filing":"0001104659-26-067485","document":"tm2615856-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926067485/tm2615856-4_4seq1.xml","form_type":"4"}},{"id":809530,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-13T21:15:06.000Z","date":"2026-04-09","kind":"gift","planned":false,"acquired":true,"shares":394696,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 9, 2026, the reporting person transferred 394,696 shares to his spouse for no consideration."}],"balance_after":394696,"source":{"system":"sec-edgar","filing":"0001104659-26-042694","document":"tm2611637-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926042694/tm2611637-1_4seq1.xml","form_type":"4"}},{"id":809529,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-13T21:15:06.000Z","date":"2026-04-09","kind":"gift","planned":false,"acquired":false,"shares":394696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 9, 2026, the reporting person transferred 394,696 shares to his spouse for no consideration."}],"balance_after":2618326,"source":{"system":"sec-edgar","filing":"0001104659-26-042694","document":"tm2611637-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926042694/tm2611637-1_4seq1.xml","form_type":"4"}},{"id":881565,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-25T23:20:23.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":20056,"price":8.28,"value":166063.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.2100 to $8.3700, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":3013022,"source":{"system":"sec-edgar","filing":"0001104659-26-019805","document":"tm267255-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926019805/tm267255-4_4seq1.xml","form_type":"4"}},{"id":900427,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-18T01:29:16.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":124882,"price":9.04,"value":1128933.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.9900 to $9.0850, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":3033078,"source":{"system":"sec-edgar","filing":"0001104659-26-016666","document":"tm266494-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465926016666/tm266494-2_4seq1.xml","form_type":"4"}},{"id":986657,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-26T21:02:06.000Z","date":"2025-11-26","kind":"gift","planned":true,"acquired":true,"shares":49754,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pravin Dugel 2024 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 26, 2025, the reporting person's spouse transferred 49,754 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":300115,"source":{"system":"sec-edgar","filing":"0001104659-25-116424","document":"tm2532258-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925116424/tm2532258-3_4seq1.xml","form_type":"4"}},{"id":986656,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-26T21:02:06.000Z","date":"2025-11-26","kind":"gift","planned":true,"acquired":false,"shares":49754,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 26, 2025, the reporting person's spouse transferred 49,754 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-116424","document":"tm2532258-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925116424/tm2532258-3_4seq1.xml","form_type":"4"}},{"id":986655,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-26T21:02:06.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":19530,"price":12.04,"value":235141.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.74 to $12.34, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":3157960,"source":{"system":"sec-edgar","filing":"0001104659-25-116424","document":"tm2532258-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925116424/tm2532258-3_4seq1.xml","form_type":"4"}},{"id":1042566,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-11T20:06:45.000Z","date":"2025-09-09","kind":"gift","planned":false,"acquired":true,"shares":49754,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 9, 2025, the reporting person transferred 49,754 shares to his spouse for no consideration."}],"balance_after":49754,"source":{"system":"sec-edgar","filing":"0001410578-25-002028","document":"tm2525848-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000141057825002028/tm2525848-1_4seq1.xml","form_type":"4"}},{"id":1042565,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-11T20:06:45.000Z","date":"2025-09-09","kind":"gift","planned":false,"acquired":false,"shares":49754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 9, 2025, the reporting person transferred 49,754 shares to his spouse for no consideration."}],"balance_after":3177490,"source":{"system":"sec-edgar","filing":"0001410578-25-002028","document":"tm2525848-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000141057825002028/tm2525848-1_4seq1.xml","form_type":"4"}},{"id":1054330,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-27T22:41:04.000Z","date":"2025-08-25","kind":"sale","planned":true,"acquired":false,"shares":21494,"price":12.04,"value":258787.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.89 to $12.18, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":3227244,"source":{"system":"sec-edgar","filing":"0001104659-25-084113","document":"tm2524438-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925084113/tm2524438-1_4seq1.xml","form_type":"4"}},{"id":1067621,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T23:02:24.000Z","date":"2025-08-11","kind":"gift","planned":false,"acquired":true,"shares":250361,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pravin Dugel 2024 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On August 11, 2025, the reporting person's spouse transferred 250,361 shares to the Pravin Dugel 2024 Irrevocable Trust (the \"Trust\") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust."}],"balance_after":250361,"source":{"system":"sec-edgar","filing":"0001104659-25-077724","document":"tm2523457-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925077724/tm2523457-1_4seq1.xml","form_type":"4"}},{"id":1067620,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T23:02:24.000Z","date":"2025-06-12","kind":"gift","planned":false,"acquired":false,"shares":50029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 12, 2025, the reporting person transferred 50,029 shares to his spouse for no consideration."}],"balance_after":3248738,"source":{"system":"sec-edgar","filing":"0001104659-25-077724","document":"tm2523457-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925077724/tm2523457-1_4seq1.xml","form_type":"4"}},{"id":1067619,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-13T23:02:24.000Z","date":"2025-04-28","kind":"gift","planned":false,"acquired":false,"shares":200332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 28, 2025, the reporting person transferred 200,332 shares to his spouse for no consideration."}],"balance_after":3298767,"source":{"system":"sec-edgar","filing":"0001104659-25-077724","document":"tm2523457-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925077724/tm2523457-1_4seq1.xml","form_type":"4"}},{"id":1111166,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Performance Stock Option (Right to Buy)","published_at":"2025-06-13T20:26:49.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":2750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The performance stock option grant was approved by the Board of Directors of Ocular Therapeutix, Inc. (the \"Corporation\") on February 11, 2025 (the \"Grant Date\"), the commencement of vesting of which was\ncontingent upon shareholder approval of an amendment to the Corporation's 2021 Stock Incentive Plan, as amended. Shareholder approval of such amendment was received on June 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to a performance stock option agreement (the \"Option Agreement\"), the shares underlying the performance stock option can be earned during the five-year period beginning on the Grant Date in four equal tranches based on the achievement of share price hurdles if the Corporation's consecutive 60-day closing share price average meets or exceeds $15.00, $20.00, $25.00, and $30.00 per share (each, a \"Share Price Hurdle\"). Shares underlying the performance stock option that are earned shall vest on the later of (i) the achievement of the applicable Share Price Hurdle or (ii) the three-year anniversary of the Grant Date, in each case subject to the reporting person's continued service to the Corporation. The performance stock option is subject to earlier vesting upon certain qualifying termination events pursuant to the Option Agreement."}],"balance_after":2750000,"derivative":{"exercise_price":7.44,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":2750000},"source":{"system":"sec-edgar","filing":"0001104659-25-059393","document":"tm2517945-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925059393/tm2517945-7_4seq1.xml","form_type":"4"}},{"id":1133027,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-27T21:37:11.000Z","date":"2025-05-23","kind":"sale","planned":true,"acquired":false,"shares":21219,"price":7.18,"value":152352.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.02 to $7.29, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":3499099,"source":{"system":"sec-edgar","filing":"0001104659-25-053087","document":"tm2516174-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925053087/tm2516174-1_4seq1.xml","form_type":"4"}},{"id":1242533,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-26T23:27:13.000Z","date":"2025-02-24","kind":"sale","planned":true,"acquired":false,"shares":21475,"price":6.87,"value":147533.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.79 to $6.97, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":3520318,"source":{"system":"sec-edgar","filing":"0001104659-25-017568","document":"tm257640-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925017568/tm257640-4_4seq1.xml","form_type":"4"}},{"id":1269364,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-14T01:38:44.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On the Grant Date, the reporting person was granted performance stock units (\"PSUs\") under the 2021 Plan and in accordance with a PSU award agreement (the \"PSU Award Agreement\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each PSU represents a right to receive one share of the Corporation's common stock. Pursuant to the PSU Award Agreement, the shares underlying the PSUs can be earned during the five-year period beginning on the Grant Date in four equal tranches based on the achievement of share price hurdles if the Company's consecutive 60-day closing share price average meets or exceeds $15.00, $20.00, $25.00, and $30.00 per share (each, a \"Share Price Hurdle\"). Shares underlying the PSUs that are earned shall vest on the later of (i) the achievement of the applicable Share Price Hurdle or (ii) the three-year anniversary of the Grant Date, in each case subject to the reporting person's continued service to the Corporation. The PSUs are subject to earlier vesting upon certain qualifying termination events pursuant to the PSU Award Agreement."}],"balance_after":3541793,"source":{"system":"sec-edgar","filing":"0001104659-25-013156","document":"tm256513-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925013156/tm256513-4_4seq1.xml","form_type":"4"}},{"id":1269363,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-14T01:38:44.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 11, 2025 (the \"Grant Date\"), the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended (the \"2021 Plan\"), of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the Grant Date and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."}],"balance_after":2041793,"source":{"system":"sec-edgar","filing":"0001104659-25-013156","document":"tm256513-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465925013156/tm256513-4_4seq1.xml","form_type":"4"}},{"id":1348938,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-27T12:47:51.000Z","date":"2024-11-25","kind":"sale","planned":true,"acquired":false,"shares":20680,"price":9.01,"value":186326.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on November 22, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.88 to $9.11, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":791793,"source":{"system":"sec-edgar","filing":"0001104659-24-123407","document":"tm2429613-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465924123407/tm2429613-1_4seq1.xml","form_type":"4"}},{"id":1421629,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-08-27T21:17:35.000Z","date":"2024-08-23","kind":"sale","planned":true,"acquired":false,"shares":20880,"price":9.02,"value":188337.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on August 22, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.88 to $9.14, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":812473,"source":{"system":"sec-edgar","filing":"0001104659-24-093500","document":"tm2422748-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465924093500/tm2422748-1_4seq1.xml","form_type":"4"}},{"id":1500025,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-28T21:00:13.000Z","date":"2024-05-23","kind":"sale","planned":true,"acquired":false,"shares":21626,"price":5.79,"value":125214.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Ocular Therapeutix, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 22, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.74 to $5.81, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":833353,"source":{"system":"sec-edgar","filing":"0001104659-24-065644","document":"tm2415610-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465924065644/tm2415610-1_4seq1.xml","form_type":"4"}},{"id":1618844,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-27T01:07:55.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":1282469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests over four years, vesting in equal monthly installments beginning on the date the reporting person commenced employment with the Corporation."}],"balance_after":1282469,"derivative":{"exercise_price":9.7,"expiration_date":"2024-02-21","underlying":"Common Stock","underlying_shares":1282469},"source":{"system":"sec-edgar","filing":"0001104659-24-027726","document":"tm247229-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465924027726/tm247229-4_4seq1.xml","form_type":"4"}},{"id":1618843,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-02-27T01:07:55.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":854979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 22, 2024, the reporting person was granted restricted stock units (\"RSUs\") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal quarterly installments, beginning on the date of grant."}],"balance_after":854979,"source":{"system":"sec-edgar","filing":"0001104659-24-027726","document":"tm247229-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1393434/000110465924027726/tm247229-4_4seq1.xml","form_type":"4"}},{"id":1830189,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-13T13:57:46.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":140000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":22.57,"expiration_date":"2032-12-19","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001104659-23-080684","document":"tm2321002-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080684/tm2321002-5_4seq1.xml","form_type":"4"}},{"id":1830188,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-13T13:57:46.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":14.83,"expiration_date":"2031-12-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-23-080684","document":"tm2321002-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080684/tm2321002-5_4seq1.xml","form_type":"4"}},{"id":1830187,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-13T13:57:46.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":7.17,"expiration_date":"2031-05-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-23-080684","document":"tm2321002-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080684/tm2321002-5_4seq1.xml","form_type":"4"}},{"id":1830186,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-13T13:57:46.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":110000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":7.5,"expiration_date":"2030-12-17","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001104659-23-080684","document":"tm2321002-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080684/tm2321002-5_4seq1.xml","form_type":"4"}},{"id":1830185,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-13T13:57:46.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Common Stock (\"IVERIC Option\") reported in this Form 4 which had a per share exercise price less than $40.00 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) the excess of $40.00 over the exercise price per share of Common Stock underlying such IVERIC Option, multiplied by (2) the total number of shares of Common Stock subject to such IVERIC Option immediately prior to the Effective Time (without regard to vesting). Each IVERIC Option reported in this Form 4 which had a per share exercise price $40.00 or greater was cancelled with no consideration payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":3.16,"expiration_date":"2030-03-31","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-23-080684","document":"tm2321002-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080684/tm2321002-5_4seq1.xml","form_type":"4"}},{"id":1830184,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2023-07-13T13:57:46.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each IVERIC restricted stock unit (\"RSU\") represented the contingent right to receive one share of Common Stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001104659-23-080684","document":"tm2321002-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080684/tm2321002-5_4seq1.xml","form_type":"4"}},{"id":1830183,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2023-07-13T13:57:46.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":70000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each IVERIC restricted stock unit (\"RSU\") represented the contingent right to receive one share of Common Stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001104659-23-080684","document":"tm2321002-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080684/tm2321002-5_4seq1.xml","form_type":"4"}},{"id":1830182,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2023-07-13T13:57:46.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":37500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each IVERIC restricted stock unit (\"RSU\") represented the contingent right to receive one share of Common Stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001104659-23-080684","document":"tm2321002-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080684/tm2321002-5_4seq1.xml","form_type":"4"}},{"id":1830181,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2023-07-13T13:57:46.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each IVERIC restricted stock unit (\"RSU\") represented the contingent right to receive one share of Common Stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-23-080684","document":"tm2321002-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080684/tm2321002-5_4seq1.xml","form_type":"4"}},{"id":1830180,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2023-07-13T13:57:46.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8625,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each IVERIC restricted stock unit (\"RSU\") represented the contingent right to receive one share of Common Stock upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each RSU reported in this Form 4 was cancelled and converted into the right to receive a cash payment (subject to any applicable tax withholding) equal to (1) $40.00, multiplied by (2) the number of shares of Common Stock subject to such RSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8625},"source":{"system":"sec-edgar","filing":"0001104659-23-080684","document":"tm2321002-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080684/tm2321002-5_4seq1.xml","form_type":"4"}},{"id":1830179,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-07-13T13:57:46.000Z","date":"2023-07-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":203035,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 11, 2023, pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated April 28, 2023, by and among IVERIC bio, Inc. (\"IVERIC\"), Astellas US Holding, Inc., Berry Merger Sub, Inc. (\"Merger Sub\") and, solely as provided by Section 8.10(b) of the Merger Agreement, Astellas Pharma Inc. (\"Astellas\"), Merger Sub merged with and into IVERIC, with IVERIC surviving the merger and becoming an indirect wholly owned subsidiary of Astellas (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), each share of IVERIC common stock (\"Common Stock\") reported in this Form 4 was automatically cancelled and was converted into the right to receive $40.00 in cash, without interest and less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-080684","document":"tm2321002-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465923080684/tm2321002-5_4seq1.xml","form_type":"4"}},{"id":1896618,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2023-05-11T17:15:22.000Z","date":"2023-05-03","kind":"exercise","planned":false,"acquired":false,"shares":4312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 3, 2021, the Reporting Person was granted 17,250 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 3, 2021, the Reporting Person was granted 17,250 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan."}],"balance_after":8625,"derivative":{"underlying":"Common Stock","underlying_shares":4312},"source":{"system":"sec-edgar","filing":"0001410939-23-000066","document":"wk-form4_1683839712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093923000066/wk-form4_1683839712.xml","form_type":"4"}},{"id":1896617,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-05-11T17:15:22.000Z","date":"2023-05-03","kind":"exercise","planned":false,"acquired":true,"shares":4312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units."}],"balance_after":203035,"source":{"system":"sec-edgar","filing":"0001410939-23-000066","document":"wk-form4_1683839712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093923000066/wk-form4_1683839712.xml","form_type":"4"}},{"id":1927639,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2023-04-04T16:27:06.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 1, 2020, the Reporting Person was granted 200,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On April 1, 2020, the Reporting Person was granted 200,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001410939-23-000036","document":"wf-form4_168064001228012.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093923000036/wf-form4_168064001228012.xml","form_type":"4"}},{"id":1927638,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-04-04T16:27:06.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units."}],"balance_after":198723,"source":{"system":"sec-edgar","filing":"0001410939-23-000036","document":"wf-form4_168064001228012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093923000036/wf-form4_168064001228012.xml","form_type":"4"}},{"id":2066841,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2023-01-04T18:35:15.000Z","date":"2023-01-02","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 16, 2021, the Reporting Person was granted 50,000 restricted stock units, which vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2023, January 2, 2024, January 2, 2025 and January 2, 2026), subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 16, 2021, the Reporting Person was granted 50,000 restricted stock units, which vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2023, January 2, 2024, January 2, 2025 and January 2, 2026), subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001410939-23-000010","document":"wf-form4_167287529901645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093923000010/wf-form4_167287529901645.xml","form_type":"4"}},{"id":2066840,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-01-04T18:35:15.000Z","date":"2023-01-02","kind":"exercise","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units."}],"balance_after":148723,"source":{"system":"sec-edgar","filing":"0001410939-23-000010","document":"wf-form4_167287529901645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093923000010/wf-form4_167287529901645.xml","form_type":"4"}},{"id":2077569,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2022-12-22T18:55:28.000Z","date":"2022-12-20","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2024, January 2, 2025, January 2, 2026 and January 2, 2027)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2024, January 2, 2025, January 2, 2026 and January 2, 2027)."}],"balance_after":70000,"derivative":{"underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001410939-22-000148","document":"wf-form4_167175331286363.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000148/wf-form4_167175331286363.xml","form_type":"4"}},{"id":2077568,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2022-12-22T18:55:28.000Z","date":"2022-12-20","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares, in approximately equal monthly installments through the fourth anniversary of the grant date."}],"balance_after":140000,"derivative":{"exercise_price":22.57,"expiration_date":"2032-12-20","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001410939-22-000148","document":"wf-form4_167175331286363.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000148/wf-form4_167175331286363.xml","form_type":"4"}},{"id":2079634,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2022-12-20T19:00:44.000Z","date":"2022-12-18","kind":"exercise","acquired":false,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 18, 2020, the Reporting Person was granted 55,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 18, 2020, the Reporting Person was granted 55,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan."}],"balance_after":27500,"derivative":{"underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001410939-22-000135","document":"wf-form4_167158082880091.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000135/wf-form4_167158082880091.xml","form_type":"4"}},{"id":2079633,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-12-20T19:00:44.000Z","date":"2022-12-18","kind":"exercise","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units."}],"balance_after":136223,"source":{"system":"sec-edgar","filing":"0001410939-22-000135","document":"wf-form4_167158082880091.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000135/wf-form4_167158082880091.xml","form_type":"4"}},{"id":2108434,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-21T19:48:50.000Z","date":"2022-11-17","kind":"exercise","acquired":false,"shares":8474,"price":10.03,"value":84994.22,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 30, 2012 and is currently excisable for all shares underlying the option."}],"balance_after":0,"derivative":{"exercise_price":10.03,"expiration_date":"2022-12-29","underlying":"Common Stock","underlying_shares":8474},"source":{"system":"sec-edgar","filing":"0001410939-22-000116","document":"wf-form4_166907811502938.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000116/wf-form4_166907811502938.xml","form_type":"4"}},{"id":2108433,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-11-21T19:48:50.000Z","date":"2022-11-17","kind":"exercise","acquired":true,"shares":8474,"price":10.03,"value":84994.22,"ownership":{"direct":true},"balance_after":122473,"source":{"system":"sec-edgar","filing":"0001410939-22-000116","document":"wf-form4_166907811502938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000116/wf-form4_166907811502938.xml","form_type":"4"}},{"id":2280752,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2022-05-05T18:02:16.000Z","date":"2022-05-03","kind":"exercise","acquired":false,"shares":4313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 3, 2021, the Reporting Person was granted 17,250 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan."}],"balance_after":12937,"derivative":{"exercise_date":"2022-05-03","underlying":"Common Stock","underlying_shares":4313},"source":{"system":"sec-edgar","filing":"0001410939-22-000061","document":"wf-form4_165178812088854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000061/wf-form4_165178812088854.xml","form_type":"4"}},{"id":2280751,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-05-05T18:02:16.000Z","date":"2022-05-03","kind":"exercise","acquired":true,"shares":4313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":113999,"source":{"system":"sec-edgar","filing":"0001410939-22-000061","document":"wf-form4_165178812088854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000061/wf-form4_165178812088854.xml","form_type":"4"}},{"id":2304110,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2022-04-05T17:46:50.000Z","date":"2022-04-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 1, 2020, the Reporting Person was granted 200,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On April 1, 2020, the Reporting Person was granted 200,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001410939-22-000044","document":"wf-form4_164919519072734.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000044/wf-form4_164919519072734.xml","form_type":"4"}},{"id":2304109,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2022-04-05T17:46:50.000Z","date":"2022-04-01","kind":"exercise","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":109686,"source":{"system":"sec-edgar","filing":"0001410939-22-000044","document":"wf-form4_164919519072734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000141093922000044/wf-form4_164919519072734.xml","form_type":"4"}},{"id":2462305,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2021-12-21T18:04:25.000Z","date":"2021-12-18","kind":"exercise","acquired":false,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 18, 2020, the Reporting Person was granted an award of 55,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 18, 2020, the Reporting Person was granted an award of 55,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan."}],"balance_after":41250,"derivative":{"underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001104659-21-152295","document":"tm2135829-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921152295/tm2135829-8_4seq1.xml","form_type":"4"}},{"id":2462304,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-12-21T18:04:25.000Z","date":"2021-12-18","kind":"exercise","acquired":true,"shares":13750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":59686,"source":{"system":"sec-edgar","filing":"0001104659-21-152295","document":"tm2135829-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921152295/tm2135829-8_4seq1.xml","form_type":"4"}},{"id":2463713,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2021-12-20T16:43:49.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2023, January 2, 2024, January 2, 2025 and January 2, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2023, January 2, 2024, January 2, 2025 and January 2, 2026)."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-21-151738","document":"tm2135829-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921151738/tm2135829-3_4seq1.xml","form_type":"4"}},{"id":2463712,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-20T16:43:49.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares, in approximately equal monthly installments through the fourth anniversary of the grant date."}],"balance_after":100000,"derivative":{"exercise_price":14.83,"expiration_date":"2031-12-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-151738","document":"tm2135829-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921151738/tm2135829-3_4seq1.xml","form_type":"4"}},{"id":2512593,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-15T16:01:39.000Z","date":"2021-11-11","kind":"exercise","acquired":false,"shares":4237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 8, 2012 and is currently exercisable for all shares underlying the option."}],"balance_after":0,"derivative":{"exercise_price":1.652,"expiration_date":"2022-02-07","underlying":"Common Stock","underlying_shares":4237},"source":{"system":"sec-edgar","filing":"0001104659-21-139120","document":"tm2132961-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921139120/tm2132961-1_4seq1.xml","form_type":"4"}},{"id":2512592,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-11-15T16:01:39.000Z","date":"2021-11-11","kind":"exercise","acquired":true,"shares":4237,"price":1.652,"value":6999.524,"ownership":{"direct":true},"balance_after":45936,"source":{"system":"sec-edgar","filing":"0001104659-21-139120","document":"tm2132961-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921139120/tm2132961-1_4seq1.xml","form_type":"4"}},{"id":2644333,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T21:38:03.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":6331,"price":1.52,"value":9623.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended June 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended June 30, 2021."}],"balance_after":12568,"source":{"system":"sec-edgar","filing":"0000899243-21-027289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924321027289/doc4.xml","form_type":"4"}},{"id":2729871,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2021-05-04T20:49:20.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":17250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock of the Registrant upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":17250,"derivative":{"underlying":"Common Stock","underlying_shares":17250},"source":{"system":"sec-edgar","filing":"0001104659-21-061241","document":"tm2115186d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921061241/tm2115186d1_4seq1.xml","form_type":"4"}},{"id":2729870,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-04T20:49:20.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares, in approximately equal monthly installments through the fourth anniversary of the grant date."}],"balance_after":35000,"derivative":{"exercise_price":7.17,"expiration_date":"2031-05-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-21-061241","document":"tm2115186d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921061241/tm2115186d1_4seq1.xml","form_type":"4"}},{"id":2757479,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy & Business"}}],"security":"Restricted Stock Units","published_at":"2021-04-05T21:30:15.000Z","date":"2021-04-01","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On April 1, 2020, the Reporting Person was granted 20,000 restricted stock units, which vested with respect to 100% of the shares subject to the award on the first anniversary of the grant date on April 1, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On April 1, 2020, the Reporting Person was granted 20,000 restricted stock units, which vested with respect to 100% of the shares subject to the award on the first anniversary of the grant date on April 1, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-21-046743","document":"tm2112227-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921046743/tm2112227-1_4seq1.xml","form_type":"4"}},{"id":2757478,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy & Business"}}],"security":"Restricted Stock Units","published_at":"2021-04-05T21:30:15.000Z","date":"2021-04-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On April 1, 2020, the Reporting Person was granted 200,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On April 1, 2020, the Reporting Person was granted 200,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2019 Inducement Stock Incentive Plan."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-21-046743","document":"tm2112227-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921046743/tm2112227-1_4seq1.xml","form_type":"4"}},{"id":2757477,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy & Business"}}],"security":"Common Stock","published_at":"2021-04-05T21:30:15.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":28301,"price":6.34,"value":179428.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of restricted stock units on April 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $6.28 to $6.47 on April 5, 2021 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range."}],"balance_after":41699,"source":{"system":"sec-edgar","filing":"0001104659-21-046743","document":"tm2112227-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921046743/tm2112227-1_4seq1.xml","form_type":"4"}},{"id":2757476,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy & Business"}}],"security":"Common Stock","published_at":"2021-04-05T21:30:15.000Z","date":"2021-04-01","kind":"exercise","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001104659-21-046743","document":"tm2112227-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921046743/tm2112227-1_4seq1.xml","form_type":"4"}},{"id":2757475,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy & Business"}}],"security":"Common Stock","published_at":"2021-04-05T21:30:15.000Z","date":"2021-04-01","kind":"exercise","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001104659-21-046743","document":"tm2112227-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465921046743/tm2112227-1_4seq1.xml","form_type":"4"}},{"id":2760994,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-03T00:30:26.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":6237,"price":1.543,"value":9623.691,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended March 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended March 31, 2021."}],"balance_after":6237,"source":{"system":"sec-edgar","filing":"0000899243-21-014674","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924321014674/doc4.xml","form_type":"4"}},{"id":2881469,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-04T02:44:38.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":17857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest in four equal quarterly installments beginning on February 1, 2021."}],"balance_after":17857,"derivative":{"exercise_price":1.46,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":17857},"source":{"system":"sec-edgar","filing":"0000899243-21-004896","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924321004896/doc4.xml","form_type":"4"}},{"id":2934469,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy & Business"}}],"security":"Restricted Stock Units","published_at":"2020-12-22T17:49:34.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":55000,"derivative":{"underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001104659-20-138670","document":"tm2039210d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920138670/tm2039210d2_4.xml","form_type":"4"}},{"id":2934468,"issuer":{"id":111416,"kind":"organization","name":"IVERIC bio, Inc.","symbol":"ISEE"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy & Business"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-22T17:49:34.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date."}],"balance_after":110000,"derivative":{"exercise_price":7.5,"expiration_date":"2030-12-17","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001104659-20-138670","document":"tm2039210d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410939/000110465920138670/tm2039210d2_4.xml","form_type":"4"}},{"id":3098412,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-26T20:44:34.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":52144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest annually on the earlier of the one year anniversary of the Grant Date or the Company's next annual meeting, subject to director's continued service on the Board at such time."}],"balance_after":52144,"derivative":{"exercise_price":1.22,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":52144},"source":{"system":"sec-edgar","filing":"0000899243-20-017777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924320017777/doc4.xml","form_type":"4"}},{"id":3484030,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T21:25:54.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":21400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest annually on the earlier of the one year anniversary of the Grant Date or the Company's next annual meeting, subject to director's continued service on the Board at such time."}],"balance_after":21400,"derivative":{"exercise_price":0.96,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":21400},"source":{"system":"sec-edgar","filing":"0000899243-19-017439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924319017439/doc4.xml","form_type":"4"}},{"id":3760809,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-16T21:21:52.000Z","date":"2018-10-26","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options fully vest on the date of grant, subject to the director's service on the Board at such time."}],"balance_after":2500,"derivative":{"exercise_price":2.05,"expiration_date":"2028-10-26","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000899243-18-029130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924318029130/doc4.xml","form_type":"4"}},{"id":3884941,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":19410,"kind":"person","name":"Dugel Pravin","position":1,"cik":"0001700917","reported_name":"Dugel Pravin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T22:07:29.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":21400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest annually on the earlier of the one year anniversary of the Grant Date or the Company's next annual meeting, subject to director's continued service on the Board at such time."}],"balance_after":21400,"derivative":{"exercise_price":4,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":21400},"source":{"system":"sec-edgar","filing":"0000899243-18-017751","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924318017751/doc4.xml","form_type":"4"}}]}